Latest News in the pharma Industry

Market News

Thermo Fisher Scientific completes acquisition of Patheon

Thermo Fisher Scientific completes acquisition of Patheon

31 Aug 2017

Patheon's CDMO capabilities coupled with Thermo's clinical trials services and bioproduction technologies expected to make Thermo and "even stronger partner" for its pharmaceutical and biotech customers.

Read more 
AstraZeneca and Takeda collaborate to develop and commercialise MEDI1341 for Parkinson’s disease

AstraZeneca and Takeda collaborate to develop and commercialise MEDI1341 for Parkinson’s disease

31 Aug 2017

MEDI1341 has the potential to achieve a better efficacy and safety profile than other alpha-synuclein antibodies.

Read more 
Cambrex invests in new analytical development and method validation laboratory at its High Point, NC Facility

Cambrex invests in new analytical development and method validation laboratory at its High Point, NC Facility

30 Aug 2017

Expansion comes as a result of increased industry demand to better understand and characterize APIs and process intermediates at the clinical stage.

Read more 
Novartis receives first ever FDA approval for a CAR-T cell therapy

Novartis receives first ever FDA approval for a CAR-T cell therapy

30 Aug 2017

Kymriah approvaed for children and young adults with B-cell ALL that is refractory or has relapsed at least twice.

Read more 
FDA approves new antibacterial drug

FDA approves new antibacterial drug

30 Aug 2017

First carbapenem-based combination product – combination of meropenem with a new class of beta-lactamase inhibitor.

Read more 
Fire at Ashland facility suspends production of BDO, THF and formaldehyde

Fire at Ashland facility suspends production of BDO, THF and formaldehyde

29 Aug 2017

Volume expected to remain somewhat constrained into the first quarter of fiscal 2018.

Read more 
Acordia's NDA generates Refusal to File letter from FDA

Acordia's NDA generates Refusal to File letter from FDA

29 Aug 2017

FDA cites two manufacturing concerns.

Read more 
Berg and AstraZeneca collaborate to identify new therapeutic targets to treat neurological disorders

Berg and AstraZeneca collaborate to identify new therapeutic targets to treat neurological disorders

28 Aug 2017

Collaboration to focus on a disease target in Parkinson's disease with Berg's Interrogative Biology technology.

Read more 
Sanofi completes the acquisition of Protein Sciences

Sanofi completes the acquisition of Protein Sciences

28 Aug 2017

An innovative quadrivalent influenza vaccine will complement Sanofi Pasteur vaccine portfolio.

Read more 
Biogen’s adalimumab biosimilar referencing Humira, is approved in the EU

Biogen’s adalimumab biosimilar referencing Humira, is approved in the EU

28 Aug 2017

Biogen becomes the first company with approved biosimilars for the three most prescribed anti-TNF biologic treatments in Europe.

Read more 
Class action lawsuit filed on behalf of investors in Teva

Class action lawsuit filed on behalf of investors in Teva

28 Aug 2017

Complaint alleges Teva failed to disclose the poor performance of its US generics business and the subsequent goodwill impairment charge stemming from the company’s purchase of Actavis Generics.

Read more 
Boehringer Ingelheim receives FDA approval for its Humira biosimilar

Boehringer Ingelheim receives FDA approval for its Humira biosimilar

29 Aug 2017

Cyltezo approved for the treatment of multiple chronic inflammatory diseases.

Read more